July 30, 2026 12:16 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Farmers storm Bhopal! Traffic crippled as protest over MSP intensifies | Supreme Court gives clean chit to Manmohan Singh in coal block scam case two years after death, accepts CBI closure report | Rahul Gandhi's 'student, idiot, andhbhakt' remark sparks uproar in Lok Sabha during anti-paper leak bill debate | Assam flood death toll climbs to 75; Over 3 lakh still affected as relief efforts intensify | 'You are simply useless': Kangana Ranaut hits back at CJP's Saurav Das in fresh Instagram attack | Assam floods: Death toll stays at 68 as over 5.24 lakh continue to battle deluge | 'Probe is meaningless if responsibility isn't fixed': Supreme Court slams Delhi Police over CJP protest crackdown | 'No protester will be left alone': CJP claims Centre shared FIR withdrawal copies after midnight talks | Bihar cop suspended after viral AK-47 firing video during NEET protest crackdown | After Dharmendra Pradhan's exit, 'E20 Janta Party' emerges, demands Nitin Gadkari's resignation over fuel policy
Covid-19 Vaccine
Image Credit: Firhad Hakim Twitter

Kolkata: Firhad Hakim gets vaccinated in Covaxin's phase 3 trial

| @indiablooms | Dec 02, 2020, at 11:42 pm

Kolkata/IBNS: Kolkata Municipal Corporation (KMC)'s chairman of board of administrators and West Bengal Minister, Firhad Hakim, on Wednesday got vaccinated in the third phase of trial of India's indigenous vaccine candidate against Covid-19, Covaxin.

The third phase trial was inaugurated in the city by West Bengal Governor Jagdeep Dhankhar at Kolkata's National Institute of Cholera and Enteric Disease (NICED)  on Tuesday.

After getting vaccinated, Hakim, who became the second candidate to take the dose of Covaxin in the trial, said, "I am fully fine after getting vaccinated."

"I don't care even if I die. My vaccination will be fruitful when the entire country will get vaccinated," he said.

A total of 1,000 people will participate in the third phase of the vaccine trial of Covaxin developed by Indian biotechnology company Bharat Biotech.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.